Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125250) titled 'Phase I/II Clinical Study of Helical Tomotherapy (TOMO) Whole Abdominopelvic Irradiation Combined with Simultaneous Integrated Boost for Radiosensitive Bone and Soft Tissue Sarcomas with Abdominopelvic Involvement' on May 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking University Shougang Hospital
Condition:
Bone and soft tissue sarcoma
Intervention:
Helical Tomotherapy (TOMO) Low-dose Whole Abdominopelvic Irradiation Combined with Simultaneous Integrated Boost Group:1. Whole abdominopelvic baseline dose: 15 Gy/10 fractions (1.5 Gy/fraction) for patients =14 years old, ...